09:51 AM EST - Cipher Pharmaceuticals Inc. : Has received Health Canada approval, on October 10, for TRULANCE® (plecanatide), a Guanylate cyclase-C (GCC) agonist in the form of a once-daily tablet for the treatment of adults with irritable bowel syndrome with constipation. Cipher Pharmaceuticals Inc.
shares T.CPH are trading up $0.095 at $1.24.
